Financial statements Synoptis Pharma

Balance sheet of Synoptis Pharma

Company age:
Age:
20 y. 11 m. 27 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of SYNOPTIS PHARMA

Year
2018
2019
2020
2021
2022
2023
Total assets 120 486 102,85 111 535 310,54 65 299 723,89 85 144 601,86 110 614 958,73 116 913 627,36
A. Fixed assets 79 607 597,76 26 883 489,99 27 103 426,40 29 184 885,26 28 918 565,52 27 467 369,90
B. Current assets 40 878 505,09 84 651 820,55 38 196 297,49 55 959 716,60 81 696 393,21 89 446 257,46
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 120 486 102,85 111 535 310,54 65 299 723,89 85 144 601,86 110 614 958,73 116 913 627,36
A. Equity 88 574 137,58 99 169 523,20 50 039 175,96 44 212 241,60 43 549 436,85 67 765 127,24
B. Liabilities and provisions for liabilities 31 911 965,27 12 365 787,34 15 260 547,93 40 932 360,26 67 065 521,88 49 148 500,12
I. Long-term liabilities 0,00 0,00 0,00 281 212,64 108 947,18 142 591,17
II. Short-term liabilities 31 500 022,92 11 531 439,34 12 552 346,68 39 604 962,50 65 790 432,99 47 731 465,04
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.